2,629 results on '"de Lemos, James A."'
Search Results
202. GOULD EDU: Primary Results of a Cluster-Randomized Trial of an Educational Intervention to Improve Guideline Adherence and Intensification of Lipid-Lowering Therapy
203. Prevalence and outcomes of intermediate saphenous vein graft lesions: Findings from the stenting of saphenous vein grafts randomized-controlled trial
204. Use of aldosterone antagonists at discharge after myocardial infarction: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry–Get with the Guidelines (GWTG)
205. Association of Cardiac Troponin I With Disease Severity and Outcomes in Patients With Pulmonary Hypertension
206. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting
207. Discordant effects of rosiglitazone on novel inflammatory biomarkers
208. A Risk Score for Predicting Coronary Artery Disease in Women With Angina Pectoris and Abnormal Stress Test Finding
209. Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction
210. Management of Acute Coronary Syndromes
211. Churches as targets for cardiovascular disease prevention: comparison of genes, nutrition, exercise, Wellness and spiritual growth (GoodNEWS) and Dallas County populations
212. Recognized Outstanding Reviewers for Circulation in 2017
213. Abstract 17140: Contemporary Epidemiology of Heart Failure in Medicare Beneficiaries Across Inpatient and Outpatient Healthcare Settings
214. Abstract 17117: Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Hospitalizations Among Uninsured in the United States
215. Abstract 15864: ICU Utilization in Stable ST-segment Elevation Myocardial Infarction Patients Treated With Rapid Reperfusion: A Report From ACTION Registry
216. Abstract 15162: Levels of High Sensitivity Troponin T and Short Term Risk for Cardiovascular Events in Older Americans: Insights From the Atherosclerosis Risk in Communities Study
217. Abstract 14140: The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Integrated Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator: Development and Validation Using Four Population-Based Cohorts
218. Ascending Aortic Dimensions in Former National Football League Athletes
219. Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings
220. Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study
221. Sex-Based Differences in Cardiometabolic Biomarkers
222. Factors Associated With Left Atrial Remodeling in the General Population
223. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction
224. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
225. Limitations of using cardiac catheterization rates to assess the quality of care for patients with non–ST-segment elevation myocardial infarction
226. Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin
227. Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients
228. Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients
229. Accuracy of Estimating Resting Oxygen Uptake and Implications for Hemodynamic Assessment
230. Circulation Best Papers 2021
231. Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
232. Abstract #1177327: Liver Fat and Cardiovascular Events: bystander or causative relationship?
233. Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis
234. Patients With Myocarditis Associated With COVID-19 Vaccination
235. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19
236. 40 - Stable Ischemic Heart Disease
237. Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: The Dallas Heart Study
238. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22)
239. Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial
240. Clinical Characteristics, Vascular Function, and Inflammation in Women With Angina in the Absence of Coronary Atherosclerosis: The Dallas Heart Study
241. Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure
242. Association of Troponin T, Detected With Highly Sensitive Assay, and Outcomes in Infective Endocarditis
243. Effect of Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention
244. High-Sensitivity Troponin after Cardiac Surgery — Is the VISION Any Clearer?
245. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD
246. SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY
247. CHARACTERISTICS OF HIGH-PERFORMING HOSPITALS FOR CARDIOGENIC SHOCK FOLLOWING ACUTE MYOCARDIAL INFARCTION
248. CORRELATION BETWEEN HOSPITAL PROCEDURAL VOLUMES AND OUTCOMES FOR TAVR AND MTEER IN THE UNITED STATES: A STS/ACC TVT REGISTRY ANALYSIS
249. Celebrating The Next Generation of Cardiovascular Investigators
250. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.